Literature DB >> 28705438

Patients' expectations and preferences regarding cancer follow-up care.

D Brandenbarg1, A J Berendsen1, G H de Bock2.   

Abstract

INTRODUCTION: Most survivors of cancer enter a follow-up routine after their treatment, the aim of which is to detect recurrence, provide psychological support, monitor treatment-related side-effects, and to evaluate care. Due to rising numbers of people with cancer and better survival of these patients, current follow-up routines are under pressure. We reviewed the literature on patients' expectations and preferences regarding this care.
METHODS: We systematically searched the databases of Pubmed, CINAHL, and PsychInfo. Studies were screened and data extraction was double performed by three authors. Data were collected from quantitative and qualitative studies and described thematically.
RESULTS: After screening, 12 full-text articles were included, comprising 849 patients aged from 28 to 90 years. Patients expect follow-up visits to detect recurrence of cancer. They want to undergo extensive testing to get reassurance. Furthermore, patients expect relevant information to be provided and to get advice about different aspects of their illness. Psychosocial support is also expected. Patients express a desire for consistency of care as well as continuity of care, and prefer long and intensive follow-up. DISCUSSION AND
CONCLUSION: After cancer, patients appear to lose confidence in their bodies and fear cancer recurrence after the end of treatment, which may lead to intensive screening wishes. This is not desirable, since care for cancer is already under pressure due to rising numbers of survivors. We have to ensure that follow-up routines are sustainable and effective. Patients should receive good information about the need for follow-up tests. Doctors should be trained to give this information.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Follow-up; Neoplasms; Patient preferences; Survivors; Survivorship care

Mesh:

Year:  2017        PMID: 28705438     DOI: 10.1016/j.maturitas.2017.07.001

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  7 in total

Review 1.  Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors.

Authors:  Andrea Chirico; Deborah Vizza; Moira Valente; Melania Lo Iacono; Maria Rosita Campagna; Tommaso Palombi; Fabio Alivernini; Fabio Lucidi; Francesco Bruno
Journal:  Support Care Cancer       Date:  2021-11-30       Impact factor: 3.603

2.  Follow-up after breast cancer: Variations, best practices, and opportunities for improvement according to health care professionals.

Authors:  Jet W Ankersmid; Jolanda C van Hoeve; Luc J A Strobbe; Yvonne E A van Riet; Cornelia F van Uden-Kraan; Sabine Siesling; Constance H C Drossaert
Journal:  Eur J Cancer Care (Engl)       Date:  2021-08-27       Impact factor: 2.328

3.  A meta-review of qualitative research on adult cancer survivors: current strengths and evidence gaps.

Authors:  Rebekah Laidsaar-Powell; Stephanie Konings; Nicole Rankin; Bogda Koczwara; Emma Kemp; Carolyn Mazariego; Phyllis Butow
Journal:  J Cancer Surviv       Date:  2019-11-19       Impact factor: 4.442

4.  Evidence-Based Follow-up for Adults With Cancer.

Authors:  Ulrich Dührsen; Karl-Matthias Deppermann; Christian Pox; Axel Holstege
Journal:  Dtsch Arztebl Int       Date:  2019-10-04       Impact factor: 5.594

5.  Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study.

Authors:  Linda Aagaard Rasmussen; Henry Jensen; Line Flytkjær Virgilsen; Alina Zalounina Falborg; Henrik Møller; Peter Vedsted
Journal:  BMC Health Serv Res       Date:  2019-12-05       Impact factor: 2.655

6.  Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial.

Authors:  A Lorenc; M Wells; T Fulton-Lieuw; P Nankivell; H Mehanna; M Jepson
Journal:  Clin Oncol (R Coll Radiol)       Date:  2021-12-01       Impact factor: 4.126

7.  Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study.

Authors:  Aline Bourdin; Julie Dubois; Rose-Anna Foley; Myriam Schluep; Olivier Bugnon; Jérôme Berger
Journal:  BMC Health Serv Res       Date:  2020-05-14       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.